Featured
Bids Coming in for NextEnergy’s Italian Photovoltaic Portfolio
At the end of last June, NextEnergy Solar Fund owned 94 plants for a total of 814MW distributed between the UK and Italy for a total gross value of $1.38 billion (£1.02 billion). Just NextEnergy Solar Fund has invested an additional $50 million in the third fund, to continue the development of its 394 MW portfolio, which has a pipeline of about 1.6 GW.
The bidding offers for the portfolio of 105 photovoltaic plants scattered in Southern Italy for a total power of 150 MW of the NextPower II fund of NextEnergy Capital are expected next week.
That is written by Reuters, specifying that at the moment there is talk of a valuation of $477 million (€420 million), then well below the $681 million (€600 million) mentioned last September, when the first rumors were spread about the start of the auction managed by Rotschild. Most of the plants have been built under government incentive schemes that provide stable revenues.
Read more on the subject and find the latest business headlines in the world with the Born2Invest mobile app.
NextPower II fund had collected $263 million (€232 million) from Prudential Assurance Company
To examine the dossier, christened Telkes Project, inspired by Maria Telkes, the late Hungarian researcher for solar energy, were all the big players of private equity in the renewable energy and infrastructure sector. In particular, Obton, Sonnedix, Equitix, and Tages were mentioned. While in September, particularly interested was Predica Energies Durables, the investment vehicle dedicated to renewable energy controlled by the group Crédit Agricole Assurance, which last January took over together with CA Vita (Italian subsidiary of the group, specializing in life insurance) 30% of EF Solare, the first operator of photovoltaics in Italy. To sell was the Third Fund of F2i sgr.
NextPower II fund had collected $263 million (€232 million) from Prudential Assurance Company, a subsidiary of M&G Prudential, and Pantheon, among others. Then last June, NextEnergy Capital raised another $232 million for the NextPower III ESG international solar fund, bringing the capital raised so far by the third fund to $530 million. This third fund, which is scheduled to close at the end of the year, aims to raise $750 million and has a hard cap of $1 billion. It focuses on selected OECD countries, including the United States, Portugal, Spain, Chile, and Italy.
NextEnergy Capital was founded in 2007 by CEO Michael Bonte-Friedheim, who leads it along with CFO and managing partner Aldo Beolchini. In addition to the funds of the NextPower series, it operates with NextEnergy Solar Fund, an investment company listed on the London Stock Exchange and with focus on the United Kingdom and other OECD countries.
At the end of last June, NextEnergy Solar Fund owned 94 plants for a total of 814MW distributed between the UK and Italy for a total gross value of $1.38 billion (£1.02 billion). Just NextEnergy Solar Fund has invested an additional $50 million in the third fund, to continue the development of its 394 MW portfolio (of which 245 MW already operational), which has a pipeline of about 1.6 GW, including 453 MW exclusively between Portugal, Chile, Poland, and Spain.
__
(Featured image by fabersam via Pixabay)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in BeBeez, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Business2 weeks ago
TopRanked.io Weekly Affiliate Digest: What’s Hot in Affiliate Marketing [EKSA Affiliates Review]
-
Biotech2 days ago
Novo Nordisk: Ozempic Gets Positive Evaluation for Kidney Treatment
-
Impact Investing1 week ago
Hera Receives 10 Million Euros from the PNRR for Agrivoltaics
-
Biotech2 weeks ago
Mason Capital Urges Grifols Again to Reconsider Dagá’s Voluntary Resignation